OPTINOSE, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.155 USD | +4.05% |
|
0.00% | -10.08% |
| 05-14 | Transcript : OptiNose, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 05-14 | Earnings Flash (OPTN) OPTINOSE Posts Q1 Revenue $14.9M, vs. Street Est of $13.7M | MT |
Presenter SpeechKen Cacciatore (Analysts)Yes. Thanks, everyone, for joining the Optinose fires...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
OptiNose, Inc. is a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists. The Company's product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing its Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and chronic rhinosinusitis without nasal polyps (also known as chronic sinusitis). XHANCE combines the EDS with a liquid formulation of fluticasone propionate, a well-characterized, second-generation corticosteroid. XHANCE is designed to deliver medication into the high and deep regions of the nasal passages where both nasal polyps and inflamed and swollen membranes can obstruct normal sinus ventilation and drainage. The Company has developed both a liquid delivery EDS and a powder delivery EDS utilizing natural functional behaviors of the upper nasal airways intended to offer better drug deposition.
Sector
Pharmaceuticals
Calendar
06/06/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.11
USD
Average target price
3.75
USD
Spread / Average Target
+237.84%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.08% | 161M | |
| +37.58% | 727B | |
| -7.89% | 354B | |
| +15.61% | 328B | |
| -0.50% | 277B | |
| +13.47% | 243B | |
| +7.35% | 205B | |
| -6.42% | 203B | |
| +3.83% | 164B | |
| -2.07% | 164B |
- Stock Market
- Equities
- OPTN Stock
- News OptiNose, Inc.
- Transcript : OptiNose, Inc. Presents at Cowen 41st Annual Health Care Conference, Mar-04-2021 01
